Bosch Provides Filling Line for Pharmalucence Facility

Pharmalucence, Inc. has selected Robert Bosch Packaging Technology, Inc. to provide an isolated pharmaceutical filling line for its new production facility in Billerica, MA. Construction of the new facility began in early 2011. Pharmalucence expects to take delivery of the isolated filling line by late Spring 2012 and it is expected to be available for commercial product production in early 2013.

Glenn Alto, Pharmalucence president and chief executive officer said, “Pharmalucence has purchased the most advanced aseptic manufacturing technology available to support its expansion into the business of pharmaceutical contract manufacturing. Our investment in Bosch technologies will help us achieve the highest level of sterility assurance and regulatory compliance for our products and for those of our clients. Partnering with Bosch adds expertise to our project team that ensures a successful manufacturing platform implementation.”

Miroslav Horvat, sales manager at Bosch Product Division Pharma Liquid said, “Bosch is excited to provide the technology and knowledge which Pharmalucence needs to implement their new drug production asset in Massachusetts. Upon completion, Pharmalucence will offer New England’s first advanced barrier isolated aseptic fill and finish facility operating in the contract manufacturing market. We appreciate that Pharmalucence has recognized our high level of expertise in pharmaceutical manufacturing equipment design and construction.”